- Home
- »
- Medical Devices
- »
-
Balloon Inflation Devices Market Size Report, 2026-2033GVR Report cover
Balloon Inflation Devices Market (2026 - 2033)
Size, Share & Trends Analysis Report By Display Type (Analog, Digital), By End Use (Hospitals & Clinics, ASCs), By Application (Interventional Cardiology, Interventional Radiology, Urology Procedures), By Region, And Segment Forecasts
Market Size, 2025
$656.3MMarket Estimate, 2026
$693.9MMarket Forecast, 2033
$1,059.2MCAGR, 2026–2033
6.2%Balloon Inflation Devices Market Summary
The global balloon inflation devices market size was valued at USD 656.3 million in 2025 and is projected to grow from USD 693.9 million in 2026 to USD 1,059.2 million by 2033, at a CAGR of 6.2% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 38.3% in 2025. Balloon inflation devices are used during minimally invasive vascular and other interventional procedures to deliver controlled pressure to inflate angioplasty balloons, dilating narrowed or obstructed blood vessels and improving blood flow.
Source: Grand View Research, IR Documents, Primary Interviews, Paid DatabasesTo learn more about this report,
Download Free Sample Report Key Market Trends & Insights
- By display type: The analog display segment dominated the market, with a revenue share of 62.3% in 2025.
- By application: The interventional cardiology segment accounted for the largest revenue share of 41.3% in 2025.
- By end use: The hospitals & clinics segment held the largest market share of 79.8% in 2025.
Regional Highlights
- Largest regional market: North America (38.3% revenue share, 2025)
- Fastest-growing regional market: Asia Pacific (highest CAGR, 2026-2033)
- By country: The U.S. held the largest share in 2025
Market Size & Forecast
- Market size in 2025: USD 656.3 Million
- Estimated market size in 2026: USD 693.9 Million
- Projected market size by 2033: USD 1,059.2 Million
- CAGR (2026-2033): 6.2%
GVR research-powered AIAsk Prism AI about the balloon inflation devices marketGet cited answers from GVR research on market growth, segments, regulations and forecasts.Start with✓ Source-linked answers ✓ Market-specific context ✓ Traceable figuresExplore Prism AI ↗
To learn more about this report, Download Free Sample Report Market Dynamics
The balloon inflation devices market is growing rapidly, driven by increasing cases of cardiovascular and peripheral artery diseases and rising adoption of minimally invasive balloon angioplasty. Advances in catheter-based technologies are also playing a role. There is a rising need for efficient and precise balloon inflation systems. Features such as pressure monitoring, ergonomic designs, and improved inflation and deflation mechanisms are expected to make procedures more efficient and accurate, leading to better patient outcomes and new opportunities for market growth.
The increasing adoption of minimally invasive cardiovascular and endovascular procedures is a key driver of the global balloon inflation devices market. Balloon inflation devices are essential for accurately inflating and deflating angioplasty balloons during coronary, peripheral vascular, and other interventional procedures. The growing prevalence of cardiovascular diseases, peripheral artery disease, and structural heart disorders has led to a higher number of catheter-based interventions worldwide. Healthcare providers increasingly prefer minimally invasive procedures due to their shorter hospital stays, reduced procedural complications, and faster patient recovery. According to an article published in PMC, more than 2 million angioplasty procedures are performed each year. This sustained rise in interventional procedures continues to support demand for precision balloon inflation devices across hospitals and catheterization laboratories.
Technological advancements in interventional cardiology are further contributing to market growth. Manufacturers are introducing digital balloon inflation devices with enhanced pressure monitoring, improved accuracy, ergonomic designs, and integrated safety features to optimize procedural outcomes. The increasing use of drug-coated balloons, specialty balloons, and advanced stent delivery systems has also heightened the need for reliable inflation devices that provide precise pressure control. In addition, expanding investments in catheterization laboratories, increasing healthcare expenditure, and growing access to advanced interventional procedures in emerging economies are supporting product adoption. These factors collectively continue to drive the growth of the global balloon inflation devices market.
The risk of procedural complications and device-related errors remains a key restraint for the global balloon inflation devices market. Balloon inflation devices require precise pressure control during angioplasty and other interventional procedures to ensure optimal balloon expansion and successful treatment outcomes. Inaccurate inflation pressure, device malfunction, or improper handling can lead to balloon rupture, vessel dissection, perforation, or incomplete lesion dilation, increasing procedural risks. These complications are anticipated to necessitate additional interventions, prolong procedure times, and increase healthcare costs. Consequently, healthcare providers place significant emphasis on device reliability, operator training, and procedural safety, which are likely to moderate product adoption and increase purchasing scrutiny.
The increasing regulatory focus on device quality and performance further limits market growth. Manufacturers are required to comply with stringent regulatory standards governing product design, manufacturing processes, clinical validation, and post-market surveillance before commercialization. Any quality issues, product recalls, or device failures may result in regulatory actions, reputational damage, and delays in product approvals. In addition, hospitals often evaluate balloon-inflation devices based on long-term performance, safety records, and compatibility with interventional systems, which makes market entry challenging for new manufacturers. These regulatory and quality-related requirements increase development costs and may slow the introduction of innovative balloon-inflation devices to the global market.
The increasing use of specialized balloons in complex coronary and peripheral vascular interventions is creating opportunities for advanced inflation devices that provide precise pressure control and reliable balloon inflation and deflation. Manufacturers can address these needs through product innovations such as digital pressure displays, enhanced pressure-locking mechanisms, ergonomic designs, and improved handling. Compatibility with drug-coated balloons, high-pressure non-compliant balloons, and specialty balloon catheters can further support product differentiation and portfolio expansion, subject to device-specific compatibility requirements.
Expanding access to interventional cardiovascular procedures presents additional opportunities for balloon inflation device manufacturers. Investments in catheterization laboratories, improvements in cardiovascular care infrastructure, and wider access to minimally invasive interventions in emerging economies can support device demand. Manufacturers can strengthen their market presence through distributor partnerships, physician training, and expanded product portfolios. In established markets, opportunities also exist through the integration of inflation devices with complementary interventional products and differentiation based on pressure accuracy, ease of use, reliability, and procedural requirements.
Technological Advancements
Technological Advancement
Description
Impact on Market
Digital Pressure Monitoring Systems
Manufacturers are incorporating digital pressure gauges and electronic monitoring systems that provide real-time inflation pressure readings with higher precision than conventional analog gauges.
Enhances procedural accuracy, reduces risk of balloon overinflation, and improves patient safety.
High-Pressure Inflation Devices
Development of inflation devices capable of delivering pressures exceeding 30 atm to support complex interventions, particularly in heavily calcified lesions and resistant stenoses.
Expands applicability in complex coronary, peripheral, and structural heart procedures.
Ergonomic Single-Hand Operation Designs
New-generation inflation syringes feature ergonomic handles, trigger mechanisms, and simplified locking systems to facilitate single-operator use.
Improves physician handling, reduces procedural fatigue, and enhances workflow efficiency in catheterization laboratories.
Enhanced Pressure Control and Fine Adjustment Mechanisms
Devices now offer incremental pressure adjustment capabilities, allowing clinicians to precisely control balloon expansion and deflation rates.
Minimizes vessel trauma, supports optimal stent deployment, and improves procedural outcomes.
Integrated Inflation and Contrast Delivery Systems
Some inflation devices combine balloon inflation functionality with contrast media delivery, reducing the need for multiple accessories during procedures.
Streamlines procedural workflow, shortens intervention times, and lowers accessory utilization.
Disposable and Pre-Sterilized Devices
Increasing availability of single-use inflation devices designed to minimize cross-contamination risks and support infection control initiatives.
Supports regulatory compliance and aligns with hospital preferences for disposable interventional accessories.
Compatibility with Advanced Balloon Technologies
Inflation devices are being optimized for use with drug-coated balloons (DCBs), scoring balloons, cutting balloons, lithotripsy balloons, and specialty angioplasty systems.
Facilitates adoption of next-generation balloon therapies in coronary and peripheral interventions.
Smart Inflation Platforms (Emerging)
Research efforts are exploring connected inflation systems capable of recording inflation pressures, duration, and procedural data for integration with digital cath lab platforms.
Expected to improve procedural documentation, quality assurance, and data-driven intervention planning.
Opportunity Analysis
Opportunity
Rationale
Potential Market Impact
Increasing Complex Coronary Interventions
Growing prevalence of calcified coronary lesions, bifurcation disease, and chronic total occlusions necessitates precise high-pressure balloon inflation capabilities.
Supports demand for advanced inflation devices with enhanced pressure control.
Expansion of Peripheral Vascular Procedures
Rising incidence of peripheral artery disease (PAD) and increasing use of balloon angioplasty in lower extremity interventions are driving accessory utilization.
Creates sustained demand across peripheral vascular centers and hybrid operating rooms.
Growth in Structural Heart Procedures
Transcatheter procedures such as TAVR, valvuloplasty, and left atrial appendage closure often require balloon preparation and controlled inflation systems.
Opens opportunities for specialized inflation devices tailored to structural interventions.
Increasing Adoption of Drug-Coated and Specialty Balloons
Wider utilization of DCBs, scoring balloons, cutting balloons, and intravascular lithotripsy balloons requires inflation devices capable of delivering precise pressure profiles.
Encourages product innovation and premium device positioning.
Emerging Market Cath Lab Expansion
Expansion of interventional cardiology infrastructure in Asia-Pacific, Latin America, and the Middle East is increasing procedure volumes and demand for disposable accessories.
Presents growth opportunities for manufacturers targeting cost-effective and high-volume product segments.
Digital Cath Lab Integration
Hospitals are increasingly investing in connected interventional suites and procedural data management systems. Smart inflation devices capable of interfacing with digital ecosystems could provide differentiation.
Creates opportunities for manufacturers to develop data-enabled inflation technologies.
Shift Toward Outpatient and Ambulatory Interventions
Increasing performance of angioplasty procedures in ambulatory surgical centers and office-based labs necessitates user-friendly, disposable inflation devices.
Expands addressable markets beyond traditional hospital settings.
Procedure Volume Growth in Interventional Specialties
Rising volumes of coronary angioplasty, peripheral interventions, neurovascular procedures, and dialysis access maintenance procedures continue to drive recurrent device consumption.
Supports stable long-term demand and recurring revenue opportunities for manufacturers.
Market Concentration & Characteristics
The balloon inflation devices industry is highly innovative, driven by advancements in pressure-control mechanisms, ergonomic device design, high-pressure inflation capabilities, and integrated pressure-monitoring technologies. Companies are developing systems that improve the precision of inflation, procedural control, usability, and balloon-deflation efficiency while supporting a wider range of interventional procedures. For instance, in July 2026, Sentante introduced the Inflante digital balloon inflation device for endovascular procedures. This system provides digitally controlled balloon inflation and deflation, real-time pressure feedback, inflation timing, and procedural-state information. It is designed to replace conventional manual indeflators and to integrate inflation data into Sentante’s broader digital cath-lab platform, thereby advancing pressure control and procedural monitoring.
“Precision in pressure control is fundamental. Digitizing this process improves control today while enabling better learning and outcomes over time.” - Tomas Baltrunas, Sentante’s co-founder and chief medical officer
The balloon inflation devices industry is experiencing moderate M&A activity, with acquisitions aimed at strengthening cardiovascular and vascular intervention portfolios and expanding capabilities across balloon-based interventional procedures. For instance, Teleflex announced an agreement to acquire substantially all of BIOTRONIK's Vascular Intervention business, adding coronary and peripheral intervention products such as balloon catheters, drug-coated balloons, and stents to its interventional portfolio. The acquisition was completed in June 2025, expanding Teleflex's presence in coronary and peripheral interventions and providing additional scale to invest in vascular technologies and innovation. The acquisition is expected to expand Teleflex's capabilities across coronary and peripheral interventions and strengthen its investment capacity in vascular technologies.
“We believe the acquisition will allow us to position this advanced coronary portfolio alongside our existing Interventional business and establish our global footprint in the fast-growing peripheral intervention market.” - Liam Kelly, Chairman, President, and Chief Executive Officer of Teleflex
To learn more about this report, Download Free Sample Report The balloon inflation devices industry is influenced by medical device regulations and requirements related to device safety, pressure performance, manufacturing quality, and clinical use. In the U.S., balloon inflation devices used in cardiovascular interventions are subject to applicable medical device regulations, with standard devices generally classified as Class II and subject to 510(k) premarket review. Regulatory requirements related to pressure accuracy, device performance, manufacturing controls, and product safety increase the need for validated and standardized balloon inflation systems.
The balloon inflation devices industry is experiencing rapid expansion, driven by the introduction of devices designed to improve pressure control, procedural consistency, and digital workflow integration. Manufacturers are expanding their offerings across manual, high-pressure, and digitally controlled inflation systems, incorporating real-time feedback and advanced pressure-control capabilities. For instance, in May 2024, Merit Medical launched the basixSKY Inflation Device. The analog device is designed to provide fast inflation with reduced rotational torque and fewer handle revolutions required to reach the target pressure. Its comfort-grip feature supports one-handed preparation, and the device is available as a standalone product and also in kits with Merit Angioplasty Packs.
The balloon inflation devices industry is experiencing moderate to high regional expansion, driven by increasing adoption of minimally invasive cardiovascular and peripheral vascular procedures in both developed and emerging healthcare markets. More hospitals are building interventional cardiology departments and offering catheter-based treatments, which is increasing the need for balloon inflation systems used in angioplasty and other vascular procedures. For instance, in April 2025, Elixir Medical received European approval and introduced the LithiX Hertz Contact intravascular lithotripsy system in Europe. This system combines a semicompliant balloon catheter with a calcium-modifying mechanism and uses low balloon inflation pressure during treatment.
Analyst Perspective
The market is experiencing steady growth, driven by the increasing volume of minimally invasive cardiovascular, peripheral vascular, neurovascular, and gastrointestinal procedures, along with the rising prevalence of coronary artery disease (CAD), peripheral artery disease (PAD), and structural heart disorders. Balloon inflation devices are critical for ensuring precise pressure control during angioplasty and catheter-based interventions, thereby improving procedural accuracy, patient safety, and clinical outcomes. Technological advancements, including high-pressure inflation systems, ergonomic single-hand operation designs, digital pressure monitoring, and single-use disposable devices, are enhancing usability and supporting wider adoption. Furthermore, the growing use of complex endovascular procedures, specialty balloons, and the continued expansion of catheterization laboratories and ambulatory interventional centers globally present significant growth opportunities. Companies with diversified interventional portfolios, strong regulatory expertise, extensive distribution networks, and sustained investments in product innovation are expected to be well-positioned to capitalize on the increasing demand for precision balloon inflation technologies.
Display Type Insights
The analog display segment accounted for the largest revenue share at 62.3% in 2025 and is anticipated to grow at the fastest CAGR over the forecast period. This growth is due to its established role in cardiovascular and peripheral interventions, simple pressure monitoring, easy operation, and wide availability in healthcare facilities. Analog inflation devices provide direct pressure readings without requiring electronic power or additional digital components, making them useful for routine angioplasty and balloon procedures. For instance, in April 2024, Atrion Medical Products (Nordson Corporation) received Health Canada approval for its QL4515 Inflation Device, a 45 mL, 15 atm single-use balloon inflation device. The device is designed for balloon inflation applications and is classified as a catheter/overtube balloon inflator. The approval expanded the availability of Atrion’s QL inflation-device portfolio in the Canadian market.
The digital display segment accounted for a significant revenue share in 2025, supported by rising demand for precise pressure monitoring, better display visibility, and improved control during balloon-based procedures. Digital inflation devices offer clear pressure readings and may include features such as inflation-time tracking and memory for previous pressures, which help improve accuracy during angioplasty and other interventions.
Application Insights
The interventional cardiology segment led the market with 41.3% revenue share in 2025, driven by the increasing use of balloon angioplasty and other catheter-based heart procedures, a higher rate of coronary artery disease, and a shift toward minimally invasive treatments. Balloon inflation devices help doctors control inflation and apply precise pressure during coronary procedures, improving accuracy and giving physicians better control; hence, they are being adopted. For instance, in October 2025, the Indian Air Force opened procurement for 60 inflation-device (indeflator) kits specifically for angioplasty. The tender required inflation devices for controlled balloon inflation during angioplasty.
The urology procedures segment is expected to register the fastest CAGR over the forecast period, driven by increasing adoption of minimally invasive urological treatments and greater use of balloon catheter procedures for urinary tract and related conditions. The increasing preference for catheter-based approaches that provide controlled dilation and reduced procedural invasiveness is expected to drive demand for balloon inflation devices in urology.
End Use Insights
The hospitals & clinics segment accounted for the largest revenue share, at 79.8% in 2025, driven by the high volume of cardiovascular, peripheral vascular, urological, and other catheter-based procedures performed in these settings. Hospitals have the specialized facilities, imaging equipment, and trained staff needed for balloon-based procedures, which drives demand for balloon inflation devices. For instance, CMS maintains dedicated national coverage and billing policies for percutaneous transluminal angioplasty and percutaneous coronary interventions, showing how common balloon-based vascular procedures are in hospitals.
To learn more about this report, Download Free Sample Report The ambulatory surgical centers segment is expected to register the fastest CAGR over the forecast period. This growth is due to more outpatient minimally invasive procedures, shorter procedure and recovery times, and more catheter-based interventions happening outside of hospitals. As more cardiovascular and other interventional procedures move into outpatient settings, the need for compact, easy-to-use balloon inflation devices is likely to increase.
Regional Insights
North America dominated the balloon inflation devices industry, accounting for the largest revenue share of 38.3% in 2025, supported by a well-established interventional cardiology infrastructure, widespread use of minimally invasive vascular procedures, and the presence of major medical device manufacturers. High healthcare spending and the ongoing advances in cardiovascular and endovascular technologies also boosted the demand. For instance, in June 2026, Medical City Fort Worth opened its fifth cardiac catheterization lab after investing USD 2.4 million. In 2025, the hospital performed about 4,700 cardiac catheterization procedures, with volumes rising by an average of 10% each year over the previous four years. This expansion allows the hospital to handle more interventional cardiology and other catheter-based heart procedures, which increases the need for balloon inflation devices used in these treatments.
To learn more about this report, Download Free Sample Report U.S. Balloon Inflation Devices Market Trends
The balloon inflation devices market in the U.S. held the largest share in the North America region in 2025, supported by a high volume of coronary and peripheral vascular procedures, growing use of minimally invasive treatments, and advances in balloon inflation technology. The presence of specialized catheterization laboratories, ambulatory and hospital-based interventional facilities, and a strong medical device manufacturing base further supported demand for both analog and digital inflation systems. In addition, the increasing adoption of complex interventional procedures has created demand for devices that provide precise pressure control, consistent inflation performance, and improved procedural handling. Product development has also focused on ergonomic designs, pressure monitoring, and enhanced usability, supporting replacement demand and adoption of newer inflation systems across interventional settings.
Europe Balloon Inflation Devices Market Trends
The balloon inflation devices market in Europe is expected to witness significant growth, owing to established cardiovascular intervention infrastructure, rising use of endovascular procedures, and advances in digital medical technology. The presence of specialized interventional centers and established healthcare systems supports the use of balloon-based interventions across coronary and peripheral vascular procedures. Supportive regulatory frameworks and investments in vascular intervention technologies are also contributing to product development and commercialization. The shift toward digitally controlled inflation systems is further evident from recent product launches. In August 2026, Sentante introduced its Inflante digital indeflator in Europe after receiving CE Mark approval. The device provides digital pressure control, real-time feedback, and procedural data capture, illustrating the industry's movement toward greater precision, repeatability, and digitization of balloon inflation during endovascular procedures.
The UK balloon inflation devices market is supported by increasing investment in cardiac catheterization infrastructure and by expanding access to minimally invasive heart procedures. As more specialized cardiac centers open and treatments like angioplasty and stenting become more available, demand for balloon inflation devices is expected to rise in both NHS and private hospitals. For instance, in September 2025, Spire Bristol Hospital opened a new cardiac catheterization lab, which offers cardiac catheterization, coronary angiography, angioplasty, stent placement, and other interventional procedures, making advanced heart care more accessible in the region.
“Investing in the latest technology, such as this new cath lab at Spire Bristol, demonstrates our commitment to deliver more complex healthcare to people when and where they need it. With NHS patients being referred to our new Bristol cath lab for treatment, we’re playing an ever-greater part in reducing the number of people waiting on NHS lists for urgent complex heart care.” - Justin Ash, CEO of Spire Healthcare
The balloon inflation devices market in Germany is anticipated to grow significantly over the forecast period, supported by its established cardiovascular treatment infrastructure, advanced catheterization skills, and more investment in modern interventional facilities. As more cardiac centers open and advanced imaging technologies are adopted, the demand for balloon inflation systems used in angioplasty and other catheter-based procedures will increase. For instance, in July 2025, Hannover Medical School opened a modern cardiac catheterization lab with advanced technology for minimally invasive diagnosis and treatment of heart diseases, thereby increasing its capacity for interventional procedures.
Asia Pacific Balloon Inflation Devices Market Trends
Asia Pacific is expected to grow at the fastest CAGR during the forecast period, driven by expanding cardiovascular treatment infrastructure, more use of minimally invasive procedures, and increased investment in advanced medical technologies. As more catheterization labs open and complex interventional procedures become more common, manufacturers of balloon inflation devices will find new opportunities in the region. For instance, in March 2026, Abbott introduced the XIENCE Skypoint drug-eluting stent in India. This stent is designed for complex percutaneous coronary interventions and shows how advanced coronary intervention technologies are expanding in Asia Pacific.
“The launch of XIENCE Skypoint in India represents an advancement for doctors treating cardiovascular disease, which remains a leading cause of mortality in India. Many patients today develop severe blockages earlier in life due to rising hypertension, diabetes, cholesterol, and lifestyle risks. This makes it essential to support doctors with stents that can safely reach difficult areas and treat a wide range of blockages.” -Tushar Sharma, general manager for Abbott’s vascular business in India and South Asia
China is developing strong capabilities in interventional cardiovascular and structural heart procedures, supported by domestic medical device development, regulatory approvals, and expanding access to transcatheter treatment technologies. The increasing commercialization of domestically developed balloon-based cardiovascular systems is expected to support demand for associated inflation devices. For instance, in February 2025, China's National Medical Products Administration approved Shanghai NewMed Medical's Prizvalve Transcatheter Aortic Valve System, which includes an aortic valve balloon-dilatation catheter and a balloon-inflation device, thereby expanding sthe range of locally produced balloon-based transcatheter cardiovascular technologies.
The balloon inflation devices market in Japan is expected to grow steadily, supported by established interventional cardiology capabilities, continued use of balloon-based therapies, and advances in cardiovascular intervention technologies. Japan has a substantial procedural base, with the J-PCI registry recording more than 247,000 PCI cases across 1,189 facilities in 2024, covering more than 90% of PCI-performing hospitals in the country. The high volume of coronary interventions, together with continued use of endovascular procedures, supports recurring demand for devices that provide accurate inflation and pressure control. In addition, the growing experience of Japanese physicians with complex coronary and peripheral interventions is likely to support demand for reliable and precision-oriented balloon inflation systems.
Latin America Balloon Inflation Devices Market Trends
The Latin America balloon inflation devices market is expected to grow steadily. More cardiovascular intervention services, higher purchases of angioplasty equipment, and wider access to catheter-based treatments drive this growth. As the volume and complexity of coronary and peripheral vascular interventions increase, demand for balloon inflation systems that enable precise pressure control and consistent balloon deployment is expected to strengthen. For instance, in January 2026, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo signed a procurement agreement covering coronary angiography catheters and post-dilation balloon catheters for coronary angioplasty. The procurement demonstrates continued investment in balloon-based interventional equipment by major hospitals in Brazil and supports demand for associated devices used during coronary angioplasty procedures, including balloon inflation devices.
The balloon inflation devices market in Brazil is supported by a large cardiovascular disease burden, an established base of interventional cardiovascular services, and continued development of healthcare infrastructure. The country's public and private healthcare systems provide a broad base for coronary and peripheral vascular interventions, supporting the use of balloon-based technologies across a range of procedures. Increasing access to catheterization laboratories and minimally invasive cardiovascular treatments is expected to support demand for balloon inflation systems, particularly devices offering precise pressure control, consistent inflation, and ease of use during complex interventions. Ongoing improvements in cardiovascular care and interventional capabilities are also expected to support adoption and replacement of balloon inflation devices across major healthcare facilities.
MEA Balloon Inflation Devices Market Trends
MEA is expected to grow steadily during the forecast period, supported by increasing investment in specialized cardiovascular services, the expansion of catheterization laboratories, and the development of advanced healthcare infrastructure across the region. Growing access to minimally invasive cardiac interventions is expected to increase demand for balloon inflation devices used in angioplasty and related procedures.
The South Africa balloon inflation devices market is expected to grow at a significant growth rate driven by a substantial cardiovascular disease burden and a gradually developing interventional cardiology infrastructure. WHO estimates that 41% of adults aged 30-79 years in South Africa had hypertension in 2024, equivalent to approximately 12 million adults, with around 9 million having uncontrolled hypertension. Cardiovascular diseases accounted for 17.8% of all registered deaths in 2024, making them the largest contributor to mortality in the country. This disease burden and the increasing access to catheterization laboratories and minimally invasive cardiovascular interventions, is expected to support demand for balloon inflation systems used in coronary and peripheral vascular procedures.
Key Balloon Inflation Devices Company Insights
Many established companies operate in the balloon inflation devices market. Their product lines include high-pressure inflation devices, analog and digital systems, urological inflation devices, and solutions for specific procedures. Major companies such as Merit Medical Systems, Boston Scientific Corporation, Medtronic, CONMED Corporation, BD, B. Braun Medical Inc., Nordson Corporation, and Cook have a strong presence. They focus on product innovation, advancing inflation technology, expanding their range of procedures, and strategic efforts to improve pressure control, inflation and deflation speed, device ergonomics, efficiency, and clinical usability.
Key Balloon Inflation Devices Companies
The following key companies have been profiled for this study on the balloon inflation devices market:
-
Merit Medical Systems
-
Boston Scientific Corporation
-
Medtronic
-
CONMED Corporation
-
BD
-
B. Braun Medical Inc.
-
Nordson Corporation
-
Cook
-
TZ Medical, Inc.
-
US Endovascular, LLC
Recent Developments
-
In July 2026, Kossel Medtech announced that its Selepump Inflation Device received approval from Japan’s Pharmaceuticals and Medical Devices Agency (PMDA), allowing it to enter the Japanese market. The device is used as an accessory for percutaneous coronary intervention (PCI) procedures and includes a precise pressure gauge, a safety lock, and an ergonomic handle. The approval gives Selepump 4 major international regulatory approvals, covering the EU, U.S., Singapore, and Japan.
-
In October 2024, Australia's TGA registered PlainSolution as a single-use catheter balloon inflation system. The device was entered in the Australian Register of Therapeutic Goods in October 2024, providing another example of regulatory commercialization of single-use balloon inflation systems outside the U.S. and European markets.
-
In August 2024, Nordson Corporation completed the acquisition of Atrion Corporation, a company that makes medical infusion and cardiovascular products. Atrion Medical supplies OEM inflation devices for balloon catheterization and fluid delivery in ENT, structural heart, and GI procedures. This acquisition added more cardiovascular and infusion applications to Nordson’s medical portfolio.
-
In May 2024, Merit Medical launched its basixSKY Inflation Device in the U.S. The analog inflation device was added to Merit's existing portfolio of digital and analog inflation systems and was designed to simplify balloon inflation through reduced rotational torque and fewer handle revolutions required to reach pressure. The device also features a comfort grip for one-handed preparation and is available both as a standalone device and in angioplasty packs with hemostasis valves.
Competitive Benchmarking
Category
Operating Strategies
Competitive Edge
Weakness
Established Players (Boston Scientific Corporation, Medtronic, BD, B. Braun Medical Inc., Cook, Merit Medical Systems)
- Expand balloon inflation device portfolios through continuous product innovation, strategic acquisitions, and partnerships with hospitals, catheterization laboratories, and interventional specialists. Invest in high-pressure inflation devices, digital pressure monitoring technologies, ergonomic syringe designs, disposable inflation systems, and integrated interventional accessories to strengthen market leadership. Focus on supporting complex cardiovascular, peripheral vascular, neurovascular, and gastrointestinal interventions through precision-controlled inflation technologies and procedure-specific product enhancements.
- Strong global brand recognition, broad interventional device portfolios, extensive clinical validation, and established relationships with healthcare providers globally. Significant R&D capabilities, regulatory expertise, manufacturing scale, and comprehensive distribution networks enable widespread adoption across cardiovascular, endovascular, and minimally invasive procedures.
- High product development, regulatory compliance, and quality assurance costs can affect profitability and pricing flexibility. Intense pricing competition, procurement pressure from hospitals, and increasing preference for bundled purchasing agreements may limit margin expansion in mature healthcare markets.
Balloon Inflation Devices Market Report Scope Table
Report Attribute
Details
Market size in 2025
USD 656.3 million
Estimated market size in 2026
USD 693.9 million
Projected market size by 2033
USD 1,059.2 million
Growth rate
CAGR of 6.2% from 2026 to 2033
Actual data
2021 - 2025
Forecast period
2026 - 2033
Quantitative units
Revenue in USD million/billion and CAGR from 2026 to 2033
Report coverage
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered
Display type, application, end use, and region
Regional scope
North America; Europe; Asia Pacific; Latin America; MEA
Country scope
U.S.; Canada; Mexico; UK; Germany; France; Italy; Spain; Norway; Denmark; Sweden; China; Japan; India; South Korea; Australia; Thailand; Brazil; Argentina; Saudi Arabia; South Africa; UAE; Kuwait
Key companies profiled
Merit Medical Systems; Boston Scientific Corporation; Medtronic; CONMED Corporation; BD; B. Braun Medical Inc.; Nordson Corporation; Cook; TZ Medical, Inc.; US Endovascular, LLC
Customization scope
Free report customization (equivalent up to 8 analyst working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
Balloon Inflation Devices Market Report Segmentation
This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global balloon inflation devices market on the basis of display type, application, end use, and region.
To learn more about this report, Download Free Sample Report -
Display Type (Revenue, USD Million, 2021 - 2033)
-
Analog Display
-
Digital Display
-
-
Application (Revenue, USD Million, 2021 - 2033)
-
Interventional Cardiology
-
Interventional Radiology
-
Peripheral Vascular Procedures
-
Gastroenterology Procedures
-
Urology Procedures
-
Others
-
-
End Use (Revenue, USD Million, 2021 - 2033)
-
Hospitals & Clinics
-
Ambulatory Surgical Centers
-
-
Regional Outlook (Revenue, USD Million, 2021 - 2033)
-
North America
-
U.S.
-
Canada
-
-
Europe
-
UK
-
Germany
-
France
-
Italy
-
Spain
-
Sweden
-
Norway
-
Denmark
-
-
Asia Pacific
-
China
-
Japan
-
India
-
Australia
-
Thailand
-
South Korea
-
-
Latin America
-
Brazil
-
Mexico
-
Argentina
-
-
Middle East and Africa
-
Saudi Arabia
-
South Africa
-
UAE
-
Kuwait
-
-
Research Methodology
The balloon inflation devices market figures in this report are based on a proven research process that combines executive interviews with secondary research from proprietary databases, company filings, and recognized regulatory and institutional sources. Market size is built through value-chain sizing-reconciling supply-side and demand-side estimates-and triangulated with bottom-up and top-down approaches. Every estimate passes multiple levels of expert validation before publication, with each balloon inflation devices segment quantified using the revenue-capture definitions in the table below.
Segment Definition
Segment - Display Type
Revenue capture definition
Analog Display
Balloon inflation devices equipped with a mechanical pressure gauge that provides a visual indication of inflation pressure through a dial and pointer. Analog systems are widely used for their simplicity, reliability, and ease of operation during interventional procedures.
Digital Display
Balloon inflation devices featuring an electronic display that provides real-time digital readings of inflation pressure. These devices offer improved measurement accuracy, enhanced readability, and precise pressure control, supporting complex interventional procedures.
Segment - Application
Revenue capture definition
Interventional Cardiology
Use of balloon inflation devices during minimally invasive cardiovascular procedures such as coronary angioplasty, balloon dilatation, stent deployment, and treatment of coronary artery disease. These devices provide controlled inflation of angioplasty balloons to restore blood flow in narrowed or blocked coronary arteries.
Interventional Radiology
Application of balloon inflation devices in image-guided minimally invasive procedures performed by interventional radiologists. These procedures include vascular dilatation, embolization support, biliary interventions, and other catheter-based treatments requiring precise balloon inflation.
Peripheral Vascular Procedures
Utilization of balloon inflation devices in the treatment of peripheral artery disease (PAD) and other vascular disorders affecting arteries outside the heart. These devices support balloon angioplasty and stent placement in peripheral vessels to restore blood circulation.
Gastroenterology Procedures
Use of balloon inflation devices during endoscopic gastrointestinal procedures to dilate strictures, treat esophageal narrowing, manage biliary and pancreatic duct obstructions, and perform other therapeutic interventions requiring controlled balloon expansion.
Urology Procedures
Application of balloon inflation devices in urological interventions, including ureteral dilation, urethral stricture treatment, nephrostomy procedures, and other minimally invasive urinary tract procedures that require balloon catheter inflation.
Others
Includes the use of balloon inflation devices in additional medical specialties such as pulmonology, gynecology, neurovascular interventions, otolaryngology (ENT), pediatric interventions, and other catheter-based procedures requiring controlled balloon inflation.
Segment - End Use
Revenue capture definition
Hospitals & Clinics
Hospitals, multispecialty clinics, and specialized healthcare facilities that utilize balloon inflation devices during interventional cardiology, radiology, gastroenterology, vascular, and urology procedures. These facilities represent the primary users due to their advanced catheterization laboratories and procedural capabilities.
Ambulatory Surgical Centers (ASCs)
Outpatient surgical facilities that perform minimally invasive catheter-based procedures without requiring overnight hospitalization. ASCs utilize balloon inflation devices for selected cardiovascular, gastrointestinal, vascular, and urological interventions, offering cost-effective and efficient patient care.
Estimation Model
Consensus-Based Estimates & Forecasting
The balloon inflation devices market presents emerging dominant opportunities, featuring global key players such as Boston Scientific Corporation; Merit Medical Systems; CONMED Corporation; Medtronic; Cook; Atrion Medical (Acquired by Nordson Corporation); BD; B. Braun Medical Inc.; US Endovascular, LLC; TZ Medical, Inc. To ensure a holistic approach, the GVR research team adopted a comprehensive methodology, considering multiple companies globally and utilizing various variables for data accuracy.
Our methodology included:
Model 1: Commodity Flow Analysis - For public players, annual reports were referenced. For private players, premium paid data sources such as S&P Global, Crunchbase, ZoomInfo, RocketReach, etc., were used for the latest revenue insights.
Model 2: Parent Market Analysis
Model 3: Country-level Multivariate Analysis Assumptions
Model 4: Segment-level Multivariate Analysis Assumptions
Model 5: Balloon Inflation Devices Market CAGR Calculations
Model 1: Commodity Flow Analysis
To learn more about this report, Download Free Sample Report Commodity flow analysis was employed to track the movement of balloon inflation devices through the value chain, from technology providers to end users. This analysis provided insights into demand generation points, intermediary roles, and ultimate consumption patterns.
Customization Table
Client Request
Customization Delivered
Value Adds
Balloon Inflation Device Adoption & Interventional Procedure Analysis
Developed a tailored analysis of the global balloon inflation devices market focused on inflation devices used in angioplasty, cardiovascular interventions, peripheral vascular procedures, endovascular therapies, urology, gastroenterology, and other minimally invasive interventions. The study assessed adoption trends across hospitals, catheterization laboratories, ambulatory surgical centers (ASCs), and specialty clinics while evaluating the rising prevalence of cardiovascular diseases, increasing volume of minimally invasive procedures, and growing utilization of balloon catheters driving market growth.
Enables stakeholders to understand evolving interventional treatment trends, identify high-growth application areas, assess procedure-driven demand opportunities, and evaluate the impact of minimally invasive technologies, increasing catheter-based interventions, and healthcare infrastructure expansion on long-term market growth.
Inflation Technology, Procedural Efficiency & Clinical Performance Assessment
Delivered a customized evaluation of balloon inflation device utilization across coronary angioplasty, peripheral angioplasty, structural heart interventions, endovascular aneurysm repair (EVAR), urological procedures, and gastrointestinal interventions. The analysis assessed advancements in high-pressure inflation devices, ergonomic syringe designs, precision pressure monitoring systems, digital pressure gauges, disposable inflation devices, and safety-lock mechanisms. Additionally, it evaluated procedural efficiency, inflation accuracy, device reliability, clinician adoption patterns, and product innovations introduced by leading companies including Boston Scientific Corporation, Merit Medical Systems, CONMED Corporation, Medtronic, Cook Medical, Atrion Medical (Nordson Corporation), BD, B. Braun Medical Inc., US Endovascular, LLC, and TZ Medical, Inc.
Provides actionable insights into commercially attractive product segments, emerging inflation technologies, evolving clinical requirements, and growth opportunities associated with enhanced procedural precision, improved patient safety, reduced procedure times, optimized balloon catheter performance, and increasing adoption of minimally invasive interventional therapies.
Interventional Device Ecosystem, Regulatory Environment & Competitive Landscape Assessment
Conducted a focused assessment of the balloon inflation devices ecosystem, including device manufacturing, component sourcing, catheter compatibility, hospital procurement practices, reimbursement frameworks, regulatory approval pathways, distribution channels, and competitive positioning. The analysis evaluated market access barriers, pricing strategies, quality assurance requirements, product innovation trends, technology adoption patterns, and competitive differentiation initiatives among leading manufacturers such as Boston Scientific Corporation, Merit Medical Systems, CONMED Corporation, Medtronic, Cook Medical, Atrion Medical (Nordson Corporation), BD, B. Braun Medical Inc., US Endovascular, LLC, and TZ Medical, Inc.
Supports strategic planning for product development, manufacturing investments, regulatory compliance, healthcare partnerships, geographic expansion, and market entry initiatives by identifying demand drivers, operational challenges, reimbursement trends, revenue opportunities, innovation priorities, and competitive advantages across the global balloon inflation devices value chain.
Frequently Asked Questions About This Report
The global balloon inflation devices market size was valued at USD 656.3 million in 2025 and is estimated at USD 639.9 million for 2026.
Key players include Boston Scientific Corporation; Merit Medical Systems; CONMED Corporation; Medtronic; Cook; Atrion Medical (Acquired by Nordson Corporation); BD; B. Braun Medical Inc.; US Endovascular, LLC; TZ Medical, Inc.
North America dominated with a 54.8% revenue share in 2025.
The global balloon inflation devices market is expected to grow at a CAGR of 6.2% from 2026 to 2033, reaching USD 1,059.2 million by 2033.
Analog display segment dominated the market, with a revenue share of 62.5% in 2025.
Interventional cardiology segment accounted for the largest revenue share of 34.6% in 2025.
Asia Pacific is the fastest-growing region over the forecast period.
Key factors include growing adoption of minimally invasive procedures, the increasing prevalence of Cardiovascular Diseases (CVDs) across economies, and the adoption of advanced technologies in the healthcare system are key factors driving market growth.
Hospitals & clinics segment held the largest market share of 69.6% in 2025.
About the Author(s)
Medical Devices Research Team
Healthcare · Medical DevicesThis report was authored by the medical devices research team at Grand View Research - comprising two research analysts, one senior research analyst, and one industry expert - with specialized expertise in the medical devices segment of the healthcare industry. All findings are based on proprietary healthcare databases, executive interviews, and regulatory analysis, subject to internal peer review prior to publication.
Last Updated:
Speak to Analyst
Customize this report to your needs - add regions, segments, or data points, with 20% free customization.
Or view our licence options:
ISO 9001:2015 & 27001:2022 Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
